Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
about
Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients.The Nephrotoxicity of VancomycinSignificant Publications on Infectious Diseases Pharmacotherapy in 2016.Telavancin in the Recent Hospital Acquired and Ventilator Associated Pneumonia (HAP/VAP) 2016 Guidelines.Increasing evidence of the nephrotoxicity of piperacillin/tazobactam and vancomycin combination therapy - what is the clinician to do?A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.Outcomes of vancomycin plus a β-lactam versus vancomycin only for the treatment of methicillin-resistant Staphylococcus aureus bacteremia.Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin.Medication Management of Patients Undergoing Transcatheter Aortic Valve Replacement.Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia.
P2860
Q38400067-A1A387D1-E122-4AAD-A02D-0EF31545F029Q38687487-23254E9C-5528-4867-834B-E4A64B8BD376Q40067736-F769815E-20D3-4397-B669-1F43EED15EFAQ40267844-2C9E4F07-A63B-406C-9BC3-E7058C625DFFQ41987133-DEE62CC7-772A-4E16-92CB-F801F70E2BE4Q41996750-DDFEC4C5-C9F9-4596-97C3-E57021C8E725Q46916150-B3A6621A-00E0-4B25-B39B-E6B8BBDC36EBQ47689239-CA6404D2-FF30-4B0E-850A-BE06A57B55EFQ48333290-BB5D8C15-5449-4325-ADFC-9E603DDA7625Q49829796-FD21209A-B345-452B-8C52-8B0F4B98594BQ55443319-A06A945B-3022-4ACF-B88A-3546677376AD
P2860
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Risk of Acute Kidney Injury in ...... se on Vancomycin and Cefepime.
@en
type
label
Risk of Acute Kidney Injury in ...... se on Vancomycin and Cefepime.
@en
prefLabel
Risk of Acute Kidney Injury in ...... se on Vancomycin and Cefepime.
@en
P2093
P2860
P356
P1476
Risk of Acute Kidney Injury in ...... ose on Vancomycin and Cefepime
@en
P2093
Amina Pervaiz
Bakht Nishan
Bhagyashri Navalkele
Emily T Martin
Hamadullah Shaikh
Jason M Pogue
Jonathan Koons
Keith S Kaye
Kyle P Murray
Madiha Salim
P2860
P304
P356
10.1093/CID/CIW709
P407
P577
2016-10-20T00:00:00Z